Medco Health Solutions

Medco Health Solutions
Name	Medco Health Solutions
Type	Public (former)
Fate	Acquired
Successor	UnitedHealth Group
Founded	1983
Headquarters	Franklin Lakes, New Jersey
Key people	Michael Gilmartin; Andrew Witty (later association via acquirer)
Industry	Pharmacy Benefit Management
Products	Prescription drug benefits, mail-order pharmacy
Num employees	26,600 (2011)

Medco Health Solutions was a major United States-based pharmacy benefit manager that operated mail-order pharmacies and managed prescription drug benefits for insurers, employers, and government programs. Originating as a subsidiary of a large pharmaceutical distributor, the company expanded through national contracts, vertical integration, and strategic acquisitions to become a significant private-sector participant in the healthcare industry. Medco's operations intersected with major actors such as Cigna, Aetna, Express Scripts, CVS Health, and UnitedHealth Group in markets for prescription fulfillment, formulary management, and utilization review.

History

Medco traced roots to the 1983 formation within Rite Aid and the expansion of pharmacy services in the 1980s alongside firms like Cardinal Health and McKesson Corporation. Through the 1990s, the company engaged with clients including Blue Cross Blue Shield Association licensees, Aetna, and Prudential Financial while competing with Express Scripts Holding Company and Caremark Rx (later CVS Caremark). In the 2000s Medco pursued growth during the tenure of executives such as William C. Weldon-era peers and negotiated formularies influenced by relationships with Pfizer, Merck & Co., Johnson & Johnson, and other major pharmaceutical manufacturers. Prior to acquisition, Medco's trajectory paralleled consolidation trends exemplified by deals involving Cigna Corporation, Humana, and regulatory scrutiny reminiscent of the Federal Trade Commission reviews of vertical integration in United States healthcare markets.

Services and Products

Medco provided mail-order pharmacy fulfillment, specialty pharmacy services, clinical management, and formulary design for clients such as IBM, General Electric, Walmart, and various state governments. Its product suite included prescription benefit management, medication adherence programs, utilization management tools, and cost-containment strategies deployed alongside partners like Eli Lilly and Company, Novartis, and Sanofi. The company operated large mail-order facilities comparable to operations run by Walgreens Boots Alliance subsidiaries and coordinated specialty drug distribution similarly to Accredo Health Group and independent specialty pharmacies. Medco's service lines interfaced with electronic health record vendors such as Epic Systems Corporation and claims clearinghouses including OptumRx competitors.

Corporate Structure and Ownership

Medco was publicly traded on the New York Stock Exchange before its acquisition, with a governance structure featuring a board of directors composed of executives and independent directors from firms like Goldman Sachs, JPMorgan Chase, and Bain Capital-affiliated networks. Its institutional shareholders included asset managers such as Vanguard Group, BlackRock, and State Street Corporation. Corporate headquarters were in Franklin Lakes, New Jersey, with operational centers in distribution hubs similar to those of FedEx and UPS. Prior chief executives and senior officers had ties to companies such as Procter & Gamble, Johnson & Johnson, and Merck, reflecting cross-industry movement among Fortune 500 leadership ranks.

Financial Performance

Medco reported multi-billion-dollar revenues in annual filings with the Securities and Exchange Commission, competing on metrics with Express Scripts and CVS Health in total prescription claims processed, gross margins, and earnings per share. Key financial drivers included mail-order volume, specialty drug costs driven by manufacturers like Amgen and Biogen, and administrative fees negotiated with clients including Aetna and Cigna. Financial results attracted analysts from firms such as Morgan Stanley, Goldman Sachs, and J.P. Morgan, and performance indicators were compared against health sector indices tracked by Standard & Poor's and NASDAQ benchmarks.

Regulatory and Legal Issues

Medco faced regulatory scrutiny from agencies including the United States Department of Justice and the Food and Drug Administration on matters of drug distribution, rebates, and conflict-of-interest concerns related to formulary placement. Litigation involved class actions and government inquiries paralleling cases against peers like Express Scripts and CVS Caremark regarding rebate disclosure, pharmacy steering, and Medicare Part D compliance overseen by Centers for Medicare & Medicaid Services. The company navigated state-level investigations in jurisdictions such as New Jersey and New York and engaged legal counsel with firms experienced in healthcare litigation and antitrust matters similar to disputes in the European Commission when multinational pharmaceutical supply chains drew cross-border attention.

Mergers, Acquisitions, and Divestitures

Medco both acquired specialty providers and was itself subject to acquisition interest culminating in a high-profile transaction with UnitedHealth Group in the early 2010s. Throughout its corporate life it acquired competitors and specialty firms in the manner of consolidation seen with Caremark Rx and Express Scripts acquisitions, and it divested non-core assets consistent with restructuring moves by Pfizer and GlaxoSmithKline in related sectors. The acquisition by UnitedHealth followed extensive negotiations, shareholder approvals, and regulatory review similar to other healthcare megadeals involving Anthem, Inc. and Cigna Corporation, reshaping the landscape for pharmacy benefit managers and major insurers.

Category:Pharmacy benefit managers Category:Companies based in New Jersey Category:Health care companies of the United States